Skip to content

Clinical trials

Phase 2 Myocardial Infarction trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 2 Country / region: Canada Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20061
20072
20083
20091
20112
20131
20142
20151
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Active, not recruiting1
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto3
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Boehringer Ingelheim1
Hamilton Health Sciences Corporation1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
KAI Pharmaceuticals1
Laval University1
Mesoblast, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction17
Acute Coronary Syndrome3
Angina, Unstable3
Coronary Artery Disease2
Heart Failure2
Myocardial Ischemia2
Angina, Stable1
Anterior Wall Myocardial Infarction1
Atrial Fibrillation1
Cardiomegaly1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.